The document discusses using surface entropy reduction (SER) mutations to improve crystallization of an RNA-Fab complex. Key points:
- SER mutations were identified on the Fab surface using software to reduce flexibility and promote crystal contacts. Mutations were incorporated using Kunkel mutagenesis.
- Mutant Fabs (Fab2SMA, Fab2SMS) were expressed at 3-4 mg/L and bound RNA similarly to the wild type Fab. Initial crystal hits were found for the mutant complexes.
- The SER approach aims to generalize to other RNA-Fab complexes, as demonstrated by binding of mutant Fabs to the VCIII riboswitch. Optimization of crystal hits is ongoing to improve diffraction resolution
6. Chaperone Assisted RNA Crystallography Crystallization chaperone - an auxiliary protein such as fragments of monoclonal antibody that binds to RNA of interest and increases its crystallization probability These chaperones 1. Mask the counterproductive surfaces while extending surfaces predisposed to forming crystal contacts 2. Provide good initial phasing information 3. Reduce conformational heterogenity 4
13. Crystal Structure (1.95 Å) of ∆C209 P4-P6/Fab2 Electron density 2Fo-Fc map calculated with Fab model-based phases. The map is shown around the selected C209 P4-P6 regions at 1 level. 4 oC, 25 mM Mg, 36~39% MPD, 0.2 M NH4OAc, 0.1 M Na Citrate pH 5.4~5.9 10
14. Lysine Glutamate RotamersRotamers Surface Entropy Reduction Rational Protein Crystallization by mutational surface engineering – ZygmuntS.Derewenda Protein-Protein interaction disfavors lysine and glutamate residues, mutating large flexible side chains with smaller amino acid residues like alanine and serine lowers the surface entropy creating hotspots for crystal contact formation Residues to be chosen should not interfere with protein function 11
15. Proof of SER Principle - globular domain of RhoGDI KtoA Series Longenecker, et al., 2001 EtoA Series Van der Waal surface representation of RhoGDI with Lysines and glutamates Mateja, et al., 2002 Derewenda & Vekilov ., 2005 12
20. Identified SER mutations K217(H) K218(H) E220(H) K190(L) E123(L) Supermutant Alanine(SMA) : ∆C209 P4-P6/Fab2SMA Supermutant Serine (SMS) : ∆C209 P4-P6/Fab2SMS Kunkel mutagenesis - method used to incorporate the mutations Since the 5 mutations are at different locations, 3 Kunkel primers were in use 16
25. Expression and Purification of Fabs P4P6Fab2SMA,P4P6Fab2SMS,P4P6Fab2 clones were transformed into 34B8 cells for expression in the CRAP media prepared as per protocol Proteins were purified by affinity chromatography (protein A column) 1- Standard protein marker 5-P4P6/Fab2SMS non-reduced 2-P4-P6/Fab2SMA reduced 6-P4P6Fab2 reduced 3- P4-P6/Fab2SMA non-reduced 7-P4P6Fab2 non-reduced 4-P4-P6/Fab2SMS reduced 21
26.
27. 24 hrs incubation 1L CRAP/ampicillin culture in 2.8 L baffled flask at 30 oC 250 RPMTrials for media optimization for Fab expression-variation in media volume
28.
29. 24 hrs incubation 500 ml CRAP/ampicillin culture in 2.8 L baffled flask at 30 oC 300 RPMIndications for good yield are After 24 hr OD600nm >6 Good observable foaming 23
30. Large scale expression and purification of ∆C209 P4-P6/Fab2SMA Expression in two batches of 3L each in CRAP/amp media After protein A purification P4P6Fab2SMA ~ 3.7mg/L 1 2 1 P4P6Fab2SMA 2 Standard marker 50 kD 25 kD 24
31. High S resin purification of ∆C209 P4-P6/Fab2SMA 50 kD 25 kD 1- Standard protein marker 4- After protein A column P4P6Fab2SMA 7- After 1st round of high S P4P6Fab2SMA 8-After 2nd round of high S P4P6Fab2SMA 25
32. Nuclease test activity data for the Fabs binding to ∆C209 P4-P6 *unrelated RNA added in all the lanes Lane1-P4P6Fab2 Lane2-P4P6Fab2SMA Lane3-P4P6Fab2SMS Lane4-Fab storage buffer Lane5-TE buffer Lane6-ddWater 1 2 3 4 5 6 Intact RNA 87% 91% 89% 90% 92% 92% 26
36. Scatter plot showing ∆C209 P4-P6 binding to wild-type and mutant Fabs 30 Hybond membrane Nitrocellulose membrane
37. Binding curves for the ∆C209 P4-P6 RNA binding to Fab2, Fab2SMA and Fab2SMS 31
38. Mobility shift analysis of the complex formation between ∆C209P4P6 RNA Fab2,Fab2SMA and Fab2SMS P4P6 Fab2 1:1.1,1:1.2,1:1.3 SMA 1:1.1,1:1.2,1:1.3,1:1.4 SMS 1:1.1,1:1.2,1:1.3,1:1.4 32 P4P6/Fab2 P4P6/Fab2 mutants P4P6 A working stoichiometric ratio of RNA: Fab =1:1.1 was determined.
40. Initial Crystal screening for P4-P6/Fab2, P4-P6/Fab2SMA, P4-P6/Fab2SMS complexes We have set up the crystal screening using the Hampton Crystal Screen I&II (96) and Index kit (96) and Natrix Crystal Screen I&II (96) Sitting drop technique Crystal screening conditions: Sample: P4-P6/Fab2, P4-P6/Fab2SMAandP4-P6/Fab2SMS Sample concentration: 12mg/ml Sample buffer: 10mM Tris pH7.5, 25mM MgCl2, 50mM NaCl, 0.5mM Spermine-4HCl and RNase inhibitor Reservoir volume: 100 μl Temperature: 4 oC and 20 oC Drop volume -1 μl Sample: 0.5 μl and Reservoir: 0.5μl 34
41. Sitting drop method ∆C209 P4-P6/Fab2 mutant crystals at 20 oC ∆C209 P4-P6/Fab2SMA crystal 0.15M DL-Malic acid pH 7.0, 20%w/v PEG 3,350 at 20 oC ∆C209 P4-P6/Fab2SMA crystal 0.2 M Magnesium chloride hexahydrate, 0.1 M Tris Ph 8.5, 3.4M 1,6-Hexanediol at 20 oC ∆C209 P4-P6/Fab2SMA 0.01 M Magnesium chloride hexahydrate, 0.05M MES monohydrate ph 5.6, 1.8 M Lithium sulfate monohydrate at 20 oC 35 ∆C209 P4-P6/Fab2SMS crystal 2.0 M NaCl, 10%w/v PEG 6000 at 20 oC
42. Sitting drop method ∆C209 P4-P6/Fab2 mutant crystals at 4 oC ∆C209 P4-P6/Fab2SMA 0.2 M Ammonium acetate, 0.1M Sodium citrate tribasicdihydrate pH 5.6, 30%v/v(+/-)-2-Methyl-2, 4-pentanediol at 4 oC ∆C209 P4-P6/Fab2SMS 0.2 M Ammonium acetate, 0.1M Sodium citrate tribasicdihydrate pH 5.6, 30%v/v(+/-)-2-Methyl-2, 4-pentanediol at 4 oC 36
48. Initial screening of all Fabscomplexed with P4-P6 side-by-side was performed to determine the crystal hit ratio using commercially available crystallization screening kits
49. Two new crystal forms showed diffraction VCIII binding SER mutant Fabs show good binding to VCIII indicating the generality of the SER mutations 40
50. Future Directions Using gel-filtration column to purify the Fab-RNA complex and employ seeding technique to get better resolution crystals Incorporation of the two other lysine mutations from the Category A K76(H), K169(L) Promotion of anti-parallel β sheet formation-crystal contact engineering 41
55. Crystals are like structure amplifiers Molecule Unit cell Crystal lattice
56. CRAP media components Adjust pH to 7.3, autoclave.Then add the following (these solutions should be filtered sterile!) to cooled CRAP media (room temperature) 47
59. If two yellow colors: M-13 binded to NAV so discard. If no color: M-13 didn’t bind to clone so no phage is present. Clone will have yellow color (binding) and control should have no color or intensity 3-10x less. Phage ELISA
60. 51 Crystal structure of class I ligase/BL3-6 (3IVK) Koldobskaya et al. NSMB 2010
61. Small scale extraction of mutated DNA Sequencing analysis of the mutated DNA 3/4 clones showed successful incorporation of alanine in both heavy chain and light chain 0/4 showed incorporation of serine in both chains Light chain serine mutations were added in the subsequent step(single strand extraction of mutated heavy chain) Kunkel mutagenesis was performed on ∆C209 P4-P6/Fab2 to incorporate the stop codon Positive clones were identified by colony PCR, DNA was extracted by mini-prep and pooled together Construction of Fabmutants 52
62. 53 Crystal contacts residues in several Fab-4D5 derivative containing structures
63. Examples of proteins crystallized using SER The RGSL domain of PDZRhoGEF Longenecker KL, et al. & Derewenda Z.S. Structure (2001) Unactivated insulin-like growth factor-1 receptor kinase Munshi, S. et al. & Kuo, L.C. ActaCryst (2003) Outer surface protein A of Borreliaburgdorferi Makabe, et al., Protein Science (2006) c-Src and its inactivatorCsk Levinson, et al., Cell (2008) 54
Neutravidin interacts with biotin to immobilize biotinylated RNANot using SAV b/c trying to make sure what’s in well really binds to target RNA. So if clone is SAV binders it won’t retain that’s why use NAV